TY - JOUR
T1 - Serotonergic recovery after (±)3,4-(methylenedioxy) methamphetamine injury
T2 - Observations in rats
AU - Scanzello, C. R.
AU - Hatzidimitriou, G.
AU - Martello, A. L.
AU - Katz, J. L.
AU - Ricaurte, G. A.
PY - 1993/1/1
Y1 - 1993/1/1
N2 - (±)3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin (5-HT) neurons in animals. In monkeys, the damage appears to be permanent. By contrast, in rats there is indication that neuronal recovery takes place, although there is question as to whether the recovery is sustained. The purpose of the present study was to examine the fate of 5-HT neurons in MDMA-treated rats, and to compare findings in the rat with those in the monkey. Rats were treated with MDMA (10 mg/kg i.p.) every 2 hr for a total dose of 40 mg/kg. Two, 8, 16, 32 and 52 weeks later, groups (n = 8) of MDMA-treated rats, along with age-matched controls (n = 8), were analyzed for regional brain 5-HT, 5-hydroxyindoleacetic acid and [3]paroxetine-labeled 5-HT uptake sites. Two weeks after MDMA, 5-HT neuronal markers were reduced markedly. Reductions ranged from 42 to 82% depending on brain region. By 16 weeks, there was evidence of recovery in some brain regions (e.g., hypothalamus and striatum) and by 32 weeks, recovery was nearly complete in most brain regions examined. One year after MDMA, recovery was still evident in all brain regions evaluated, although closer inspection of the group data revealed that whereas most MDMA-treated rats recovered, some did not. These few animals had severe and enduring serotonergic deficits in multiple brain regions. Morphologic immunocytochemical studies yielded results which corroborated the neurochemical findings. Together, these observations suggest that 5-HT neurons in most (but not all) rats recover from MDMA injury, and that in those rats which recover, recovery is maintained for at least 1 year after MDMA treatment. Further studies are needed to determine if recovery is sustained for longer than 1 year, and to define the factors which govern 5-HT neuronal recovery after MDMA injury.
AB - (±)3,4-Methylenedioxymethamphetamine (MDMA) is a recreational drug of abuse which damages serotonin (5-HT) neurons in animals. In monkeys, the damage appears to be permanent. By contrast, in rats there is indication that neuronal recovery takes place, although there is question as to whether the recovery is sustained. The purpose of the present study was to examine the fate of 5-HT neurons in MDMA-treated rats, and to compare findings in the rat with those in the monkey. Rats were treated with MDMA (10 mg/kg i.p.) every 2 hr for a total dose of 40 mg/kg. Two, 8, 16, 32 and 52 weeks later, groups (n = 8) of MDMA-treated rats, along with age-matched controls (n = 8), were analyzed for regional brain 5-HT, 5-hydroxyindoleacetic acid and [3]paroxetine-labeled 5-HT uptake sites. Two weeks after MDMA, 5-HT neuronal markers were reduced markedly. Reductions ranged from 42 to 82% depending on brain region. By 16 weeks, there was evidence of recovery in some brain regions (e.g., hypothalamus and striatum) and by 32 weeks, recovery was nearly complete in most brain regions examined. One year after MDMA, recovery was still evident in all brain regions evaluated, although closer inspection of the group data revealed that whereas most MDMA-treated rats recovered, some did not. These few animals had severe and enduring serotonergic deficits in multiple brain regions. Morphologic immunocytochemical studies yielded results which corroborated the neurochemical findings. Together, these observations suggest that 5-HT neurons in most (but not all) rats recover from MDMA injury, and that in those rats which recover, recovery is maintained for at least 1 year after MDMA treatment. Further studies are needed to determine if recovery is sustained for longer than 1 year, and to define the factors which govern 5-HT neuronal recovery after MDMA injury.
UR - http://www.scopus.com/inward/record.url?scp=0027339403&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027339403&partnerID=8YFLogxK
M3 - Article
C2 - 7680719
AN - SCOPUS:0027339403
SN - 0022-3565
VL - 264
SP - 1484
EP - 1491
JO - Journal of Pharmacology and Experimental Therapeutics
JF - Journal of Pharmacology and Experimental Therapeutics
IS - 3
ER -